Aim The need or otherwise for lateral pelvic node dissection (LPND) in rectal cancer patients
with clinical lateral pelvic node metastasis (LPNM) after neoadjuvant chemoradiotherapy …

Aim It is still controversial whether the addition of lateral pelvic lymph node (LPN) dissection
(LPND) to total mesorectal excision (TME) can provide a survival benefit after neoadjuvant …

Background Although lateral pelvic node dissection (LPND) is recommended for rectal
cancer with clinically metastatic lateral pelvic lymph nodes (LPNs), LPNs may respond to …

Abstract Background and Objectives There is no consensus on the safety and indications of
lateral pelvic lymph node dissection (LPND) for patients with clinical lateral pelvic node …

Abstract Background In 15% to 25% of patients, the lateral pelvic lymph nodes (LPN) are
known to be involved especially with rectal tumors lying below the peritoneal reflection …

Purpose The prognostic significance and treatment of lateral pelvic lymph node metastasis
(mLPLN) in rectal cancer patients receiving neoadjuvant chemoradiotherapy (nCRT) are not …

Background Lateral pelvic node metastasis is one of the major causes of local recurrence in
advanced rectal cancer after preoperative chemoradiotherapy (CRT). However, lateral …

Objective: Lateral pelvic lymph node (LPLN) metastases are an important cause of
preventable local failure in rectal cancer. The aim of this study was to evaluate clinical and …

Background Although lateral pelvic lymph node (LPN) metastasis is a major cause of local
recurrence in patients with rectal cancer, controversy still remains on the treatment of …

Background Synchronous lateral pelvic lymph node (LPLN) involvement occurs in a
significant number of patients with rectal cancer. The aim of this study is to determine the …